These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8186671)

  • 41. Psychopathology and clinical features in an Italian sample of patients with myofascial and temporomandibular joint pain: preliminary data.
    Nifosì F; Violato E; Pavan C; Sifari L; Novello G; Guarda Nardini L; Manfredini D; Semenzin M; Pavan L; Marini M
    Int J Psychiatry Med; 2007; 37(3):283-300. PubMed ID: 18314857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factor validation of the addiction severity index scale structure in persons with concurrent disorders.
    Currie SR; El-Guebaly N; Coulson R; Hodgins D; Mansley C
    Psychol Assess; 2004 Sep; 16(3):326-9. PubMed ID: 15456388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defining subgroups of dual diagnosis patients for service planning.
    Lehman AF; Myers CP; Dixon LB; Johnson JL
    Hosp Community Psychiatry; 1994 Jun; 45(6):556-61. PubMed ID: 8088734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Personality disorders in substance abusers: validation of the DIP-Q through principal components factor analysis and canonical correlation analysis.
    Hesse M
    BMC Psychiatry; 2005 May; 5():24. PubMed ID: 15910688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics of persons with severe mental illness and substance abuse in rural areas.
    Barry KL; Fleming MF; Greenley JR; Kropp S; Widlak P
    Psychiatr Serv; 1996 Jan; 47(1):88-90. PubMed ID: 8925354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnosing comorbidity in substance abusers. Computer assessment and clinical validation.
    Ross HE; Swinson R; Larkin EJ; Doumani S
    J Nerv Ment Dis; 1994 Oct; 182(10):556-63. PubMed ID: 7931203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What characterizes substance abusers who commit suicide attempts? Factors related to Axis I disorders and patterns of substance use disorders. A study of treatment-seeking substance abusers in Norway.
    Landheim AS; Bakken K; Vaglum P
    Eur Addict Res; 2006; 12(2):102-8. PubMed ID: 16543746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer?
    Kranzler HR; Kadden RM; Burleson JA; Babor TF; Apter A; Rounsaville BJ
    Compr Psychiatry; 1995; 36(4):278-88. PubMed ID: 7554872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psychiatric comorbidity and severity of dependence on substance users: how it impacts on their health-related quality of life?
    Lozano ÓM; Rojas AJ; Fernández Calderón F
    J Ment Health; 2017 Apr; 26(2):119-126. PubMed ID: 27128492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validity issues in using the Millon-II with substance abusers.
    Bishop DR
    Psychol Rep; 1993 Aug; 73(1):27-33. PubMed ID: 8367567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychiatric comorbidity in pathological gamblers seeking treatment.
    Ibáñez A; Blanco C; Donahue E; Lesieur HR; Pérez de Castro I; Fernández-Piqueras J; Sáiz-Ruiz J
    Am J Psychiatry; 2001 Oct; 158(10):1733-5. PubMed ID: 11579014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychiatric disorders in substance-abusing adolescent inpatients: a pilot study.
    Stowell RJ; Estroff TW
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1036-40. PubMed ID: 1429401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hospital-based adolescent substance abuse treatment: comorbidity, outcomes, and gender.
    Rivers SM; Greenbaum RL; Goldberg E
    J Nerv Ment Dis; 2001 Apr; 189(4):229-37. PubMed ID: 11339318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A survey of hospitals in New York State treating psychiatric patients with chemical abuse disorders.
    Haugland G; Siegel C; Alexander MJ; Galanter M
    Hosp Community Psychiatry; 1991 Dec; 42(12):1215-20. PubMed ID: 1667307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychiatric referrals associated with substance use disorders: prevalence and gender differences. European Consultation-Liaison Workgroup.
    Alaja R; Seppä K; Sillanaukee P; Tienari P; Huyse FJ; Herzog T; Malt UF; Lobo A
    Alcohol Clin Exp Res; 1997 Jun; 21(4):620-6. PubMed ID: 9194914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of psychoactive substance use on the reliability of psychiatric diagnosis.
    Corty E; Lehman AF; Myers CP
    J Consult Clin Psychol; 1993 Feb; 61(1):165-70. PubMed ID: 8450103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of Axis II personality disorders among female substance abusers.
    Butler SF; Gaulier B; Haller D
    Psychol Rep; 1991 Jun; 68(3 Pt 2):1344-6. PubMed ID: 1924631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlates of dissociative symptoms in substance abusers.
    Hodgins DC; Pennington M; el-Guebaly N; Dufour M
    J Nerv Ment Dis; 1996 Oct; 184(10):636-9. PubMed ID: 8917162
    [No Abstract]   [Full Text] [Related]  

  • 60. Co-morbid post-traumatic stress disorder in a substance misusing clinical population.
    Reynolds M; Mezey G; Chapman M; Wheeler M; Drummond C; Baldacchino A
    Drug Alcohol Depend; 2005 Mar; 77(3):251-8. PubMed ID: 15734225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.